Immunotherapy holds the potential to induce durable responses, but only a minority of
patients currently respond. The etiologies of primary and secondary resistance to …

Recent developments have set the stage for immunotherapy as a supplement to
conventional cancer treatment. Consequently, a significant effort is required to further …

Synovial sarcoma (SS), an aggressive soft tissue sarcoma with a predilection for the
extremities of young adults, harbors the pathognomonic t (X; 18)(p11; q11) translocation …

Cancer/testis (CT) antigens are a category of tumor antigens with normal expression
restricted to male germ cells in the testis but not in adult somatic tissues. In some cases, CT …

Cancer testis antigens (CTA) are a large family of tumor-associated antigens expressed in
human tumors of different histological origin, but not in normal tissues except for testis and …

Cancer/testis (CT) antigens are immunogenic in cancer patients, exhibit highly tissue-
restricted expression, and are considered promising target molecules for cancer vaccines …

Cancer/testis antigens (CTAs) are named based on their expression pattern that is restricted
in a number of normal and abnormal tissues. Tumor cells frequently express antigens whose …

The present Update on synovial sarcoma (SS) follows the pattern of previous ones in that it
presents findings related to this tumor which have appeared since 1994 when our book was …

Cancer/testis‐associated genes (CTAs) are a subgroup of tumor antigens with a restricted
expression in testis and malignancies. During the last decade, many of these …

Synovial sarcomas are high‐grade malignant mesenchymal tumors with biphasic (BSS) and
monophasic (MSS) variants that carry a pathognomonic cytogenetic alteration, t (X; 18) …